Plus Therapeutics Ownership 2024 | Who Owns Plus Therapeutics Now?

Overview RevenueFinancials Chart Transcripts

Institutional Ownership

0.39%

Insider Ownership

1.87%

Retail Ownership

97.74%

Institutional Holders

21.00

Plus Therapeutics Institutional Shareholders

Institutional Shareholders by % of Total Shares

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
WELLS FARGO & COMPANY/MN	-	-	-	-234	-100.00%	-	Jun 30, 2023
NORTHERN TRUST CORP	-	-	-	-57,581	-100.00%	-	Jun 30, 2023
STATE STREET CORP	-	-	-	-34,414	-100.00%	-	Jun 30, 2023
VANGUARD GROUP INC	-	-	-	-1,092,953	-100.00%	-	Jun 30, 2023
FMR LLC	-	-	-	-2,000	-100.00%	-	Jun 30, 2023
MORGAN STANLEY	-	-	-	-10	-100.00%	-	Jun 30, 2023
GROUP ONE TRADING, L.P.	-	-	-	-21	-100.00%	-	Jun 30, 2023
UMB BANK, N.A.	-	-	-	-54	-100.00%	-	Jun 30, 2023
RENAISSANCE TECHNOLOGIES LLC	-	-	-	-264,310	-100.00%	-	Jun 30, 2023
GEODE CAPITAL MANAGEMENT, LLC	-	-	-	-255,148	-100.00%	-	Jun 30, 2023
MILLENNIUM MANAGEMENT LLC	-	-	-	-69,669	-100.00%	-	Jun 30, 2023
BLACKROCK INC.	-	-	-	-104,427	-100.00%	-	Jun 30, 2023
TWO SIGMA SECURITIES, LLC	-	-	-	-23,449	-100.00%	-	Jun 30, 2023
TWO SIGMA ADVISERS, LP	-	-	-	-32,100	-100.00%	-	Jun 30, 2023
TOWER RESEARCH CAPITAL LLC (TRC)	-	-	-	-9,056	-100.00%	-	Jun 30, 2023
CREATIVE PLANNING	-	-	-	-33,540	-100.00%	-	Jun 30, 2023
ALLWORTH FINANCIAL LP	-	-	-	-1	-100.00%	-	Jun 30, 2023
UBS GROUP AG	-	-	-	-13	-100.00%	-	Jun 30, 2023
ADVISOR GROUP HOLDINGS, INC.	-	-	-	-2,003	-100.00%	-	Jun 30, 2023
GREAT VALLEY ADVISOR GROUP, INC.	-	-	-	-33,600	-100.00%	-	Jun 30, 2023

Plus Therapeutics's largest institutional shareholder is WELLS FARGO & COMPANY/MN, holding 0.00% of the company's total share outstanding, currently valued at -. The top 10 institutional shareholders own together 0.00% of the company.

Institutional Shareholders by % of Total Assets

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
WELLS FARGO & COMPANY/MN	-	-	-	-234	-100.00%	-	Jun 30, 2023
NORTHERN TRUST CORP	-	-	-	-57,581	-100.00%	-	Jun 30, 2023
STATE STREET CORP	-	-	-	-34,414	-100.00%	-	Jun 30, 2023
VANGUARD GROUP INC	-	-	-	-1,092,953	-100.00%	-	Jun 30, 2023
FMR LLC	-	-	-	-2,000	-100.00%	-	Jun 30, 2023
MORGAN STANLEY	-	-	-	-10	-100.00%	-	Jun 30, 2023
GROUP ONE TRADING, L.P.	-	-	-	-21	-100.00%	-	Jun 30, 2023
UMB BANK, N.A.	-	-	-	-54	-100.00%	-	Jun 30, 2023
RENAISSANCE TECHNOLOGIES LLC	-	-	-	-264,310	-100.00%	-	Jun 30, 2023
GEODE CAPITAL MANAGEMENT, LLC	-	-	-	-255,148	-100.00%	-	Jun 30, 2023
MILLENNIUM MANAGEMENT LLC	-	-	-	-69,669	-100.00%	-	Jun 30, 2023
BLACKROCK INC.	-	-	-	-104,427	-100.00%	-	Jun 30, 2023
TWO SIGMA SECURITIES, LLC	-	-	-	-23,449	-100.00%	-	Jun 30, 2023
TWO SIGMA ADVISERS, LP	-	-	-	-32,100	-100.00%	-	Jun 30, 2023
TOWER RESEARCH CAPITAL LLC (TRC)	-	-	-	-9,056	-100.00%	-	Jun 30, 2023
CREATIVE PLANNING	-	-	-	-33,540	-100.00%	-	Jun 30, 2023
ALLWORTH FINANCIAL LP	-	-	-	-1	-100.00%	-	Jun 30, 2023
UBS GROUP AG	-	-	-	-13	-100.00%	-	Jun 30, 2023
ADVISOR GROUP HOLDINGS, INC.	-	-	-	-2,003	-100.00%	-	Jun 30, 2023
GREAT VALLEY ADVISOR GROUP, INC.	-	-	-	-33,600	-100.00%	-	Jun 30, 2023

The largest Plus Therapeutics shareholder by % of total assets is WELLS FARGO & COMPANY/MN. The company owns 0.00 shares of Plus Therapeutics (PSTV), representing 0.00% of its total assets.

Institutional Buyers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
ALLWORTH FINANCIAL LP	-	-	-	-1	-100.00%	-	Jun 30, 2023
MORGAN STANLEY	-	-	-	-10	-100.00%	-	Jun 30, 2023
UBS GROUP AG	-	-	-	-13	-100.00%	-	Jun 30, 2023
GROUP ONE TRADING, L.P.	-	-	-	-21	-100.00%	-	Jun 30, 2023
UMB BANK, N.A.	-	-	-	-54	-100.00%	-	Jun 30, 2023
WELLS FARGO & COMPANY/MN	-	-	-	-234	-100.00%	-	Jun 30, 2023
FMR LLC	-	-	-	-2,000	-100.00%	-	Jun 30, 2023
ADVISOR GROUP HOLDINGS, INC.	-	-	-	-2,003	-100.00%	-	Jun 30, 2023
TOWER RESEARCH CAPITAL LLC (TRC)	-	-	-	-9,056	-100.00%	-	Jun 30, 2023
TWO SIGMA SECURITIES, LLC	-	-	-	-23,449	-100.00%	-	Jun 30, 2023
TWO SIGMA ADVISERS, LP	-	-	-	-32,100	-100.00%	-	Jun 30, 2023
CREATIVE PLANNING	-	-	-	-33,540	-100.00%	-	Jun 30, 2023
GREAT VALLEY ADVISOR GROUP, INC.	-	-	-	-33,600	-100.00%	-	Jun 30, 2023
STATE STREET CORP	-	-	-	-34,414	-100.00%	-	Jun 30, 2023
NORTHERN TRUST CORP	-	-	-	-57,581	-100.00%	-	Jun 30, 2023
MILLENNIUM MANAGEMENT LLC	-	-	-	-69,669	-100.00%	-	Jun 30, 2023
BLACKROCK INC.	-	-	-	-104,427	-100.00%	-	Jun 30, 2023
GEODE CAPITAL MANAGEMENT, LLC	-	-	-	-255,148	-100.00%	-	Jun 30, 2023
RENAISSANCE TECHNOLOGIES LLC	-	-	-	-264,310	-100.00%	-	Jun 30, 2023
VANGUARD GROUP INC	-	-	-	-1,092,953	-100.00%	-	Jun 30, 2023

As of Jun 30 2023, Plus Therapeutics's largest institutional buyer is ALLWORTH FINANCIAL LP. The company purchased -1.00 stocks of PSTV, valued at -.

Institutional Sellers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
VANGUARD GROUP INC	-	-	-	-1,092,953	-100.00%	-	Jun 30, 2023
RENAISSANCE TECHNOLOGIES LLC	-	-	-	-264,310	-100.00%	-	Jun 30, 2023
GEODE CAPITAL MANAGEMENT, LLC	-	-	-	-255,148	-100.00%	-	Jun 30, 2023
BLACKROCK INC.	-	-	-	-104,427	-100.00%	-	Jun 30, 2023
MILLENNIUM MANAGEMENT LLC	-	-	-	-69,669	-100.00%	-	Jun 30, 2023
NORTHERN TRUST CORP	-	-	-	-57,581	-100.00%	-	Jun 30, 2023
STATE STREET CORP	-	-	-	-34,414	-100.00%	-	Jun 30, 2023
GREAT VALLEY ADVISOR GROUP, INC.	-	-	-	-33,600	-100.00%	-	Jun 30, 2023
CREATIVE PLANNING	-	-	-	-33,540	-100.00%	-	Jun 30, 2023
TWO SIGMA ADVISERS, LP	-	-	-	-32,100	-100.00%	-	Jun 30, 2023
TWO SIGMA SECURITIES, LLC	-	-	-	-23,449	-100.00%	-	Jun 30, 2023
TOWER RESEARCH CAPITAL LLC (TRC)	-	-	-	-9,056	-100.00%	-	Jun 30, 2023
ADVISOR GROUP HOLDINGS, INC.	-	-	-	-2,003	-100.00%	-	Jun 30, 2023
FMR LLC	-	-	-	-2,000	-100.00%	-	Jun 30, 2023
WELLS FARGO & COMPANY/MN	-	-	-	-234	-100.00%	-	Jun 30, 2023
UMB BANK, N.A.	-	-	-	-54	-100.00%	-	Jun 30, 2023
GROUP ONE TRADING, L.P.	-	-	-	-21	-100.00%	-	Jun 30, 2023
UBS GROUP AG	-	-	-	-13	-100.00%	-	Jun 30, 2023
MORGAN STANLEY	-	-	-	-10	-100.00%	-	Jun 30, 2023
ALLWORTH FINANCIAL LP	-	-	-	-1	-100.00%	-	Jun 30, 2023

As of Jun 30 2023, Plus Therapeutics's biggest institutional seller is VANGUARD GROUP INC. The company sold -1.09M shares of PSTV, valued at -.

Institutional New positions

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date

Institutional Sold Out

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
VANGUARD GROUP INC	-	-	-	-1,092,953	-100.00%	-	Jun 30, 2023
RENAISSANCE TECHNOLOGIES LLC	-	-	-	-264,310	-100.00%	-	Jun 30, 2023
GEODE CAPITAL MANAGEMENT, LLC	-	-	-	-255,148	-100.00%	-	Jun 30, 2023
BLACKROCK INC.	-	-	-	-104,427	-100.00%	-	Jun 30, 2023
MILLENNIUM MANAGEMENT LLC	-	-	-	-69,669	-100.00%	-	Jun 30, 2023
NORTHERN TRUST CORP	-	-	-	-57,581	-100.00%	-	Jun 30, 2023
STATE STREET CORP	-	-	-	-34,414	-100.00%	-	Jun 30, 2023
GREAT VALLEY ADVISOR GROUP, INC.	-	-	-	-33,600	-100.00%	-	Jun 30, 2023
CREATIVE PLANNING	-	-	-	-33,540	-100.00%	-	Jun 30, 2023
TWO SIGMA ADVISERS, LP	-	-	-	-32,100	-100.00%	-	Jun 30, 2023
TWO SIGMA SECURITIES, LLC	-	-	-	-23,449	-100.00%	-	Jun 30, 2023
TOWER RESEARCH CAPITAL LLC (TRC)	-	-	-	-9,056	-100.00%	-	Jun 30, 2023
ADVISOR GROUP HOLDINGS, INC.	-	-	-	-2,003	-100.00%	-	Jun 30, 2023
FMR LLC	-	-	-	-2,000	-100.00%	-	Jun 30, 2023
WELLS FARGO & COMPANY/MN	-	-	-	-234	-100.00%	-	Jun 30, 2023
UMB BANK, N.A.	-	-	-	-54	-100.00%	-	Jun 30, 2023
GROUP ONE TRADING, L.P.	-	-	-	-21	-100.00%	-	Jun 30, 2023
UBS GROUP AG	-	-	-	-13	-100.00%	-	Jun 30, 2023
MORGAN STANLEY	-	-	-	-10	-100.00%	-	Jun 30, 2023
ALLWORTH FINANCIAL LP	-	-	-	-1	-100.00%	-	Jun 30, 2023

Plus Therapeutics's largest sold out institutional shareholder by shares sold is VANGUARD GROUP INC, sold -1.09M shares, valued at -, as of undefined.

Plus Therapeutics Mutual Fund Holders

Name	% Total Assets	Total Shares	Change Amount	Change %	Date
PROFESSIONALLY MANAGED PORTFOLIOS	0.00%	330,168	-	-	Feb 29, 2024
VANGUARD INDEX FUNDS	0.00%	1,092,953	-	-	Mar 31, 2024
FIDELITY CONCORD STREET TRUST	0.00%	244,640	-	-	Feb 29, 2024
FIDELITY CONCORD STREET TRUST	0.00%	28,487	2,644	10.23%	Feb 29, 2024
VANGUARD INDEX FUNDS	0.00%	32,541	-32,541	-50.00%	Mar 31, 2024
Dimensional ETF Trust	0.00%	7,087	-	-	Jan 31, 2024
USAA MUTUAL FUNDS TRUST	0.00%	3,102	-	-	Jan 31, 2024
DFA INVESTMENT DIMENSIONS GROUP INC	0.00%	4,993	-	-	Jan 31, 2024
EQ ADVISORS TRUST	0.00%	2,202	-	-	Mar 31, 2024
Blackstone Alternative Investment Funds	0.00%	100	-	-	Mar 31, 2023

Plus Therapeutics's largest mutual fund holder by % of total assets is "PROFESSIONALLY MANAGED PORTFOLIOS", owning 330.17K shares, compromising 0.00% of its total assets.

Plus Therapeutics Institutional Ownership Trends

Institutional Holdings Trend

Date	Holdings	Change %
31 Mar, 23	21	-16.00%
31 Dec, 22	25	25.00%
30 Sep, 22	20	5.26%
30 Jun, 22	19	26.67%
31 Mar, 22	15	-6.25%
31 Dec, 21	16	33.33%
30 Sep, 21	12	-14.29%
30 Jun, 21	14	55.56%
31 Mar, 21	9	-18.18%
31 Dec, 20	11	-8.33%
30 Sep, 20	12	100.00%
30 Jun, 20	6	-
31 Mar, 20	6	-45.45%
31 Dec, 19	11	10.00%
30 Sep, 19	10	-

As of 31 Mar 23, 21 institutions are holding Plus Therapeutics's shares, representing a decrease of -16.00% compared to the previous quarter.

Shares Outstanding Trend

Date	Shares Outstanding	Change %
31 Mar, 23	2,026,813	-26.39%
31 Dec, 22	2,753,627	-22.37%
30 Sep, 22	3,547,118	-0.88%
30 Jun, 22	3,578,489	9.84%
31 Mar, 22	3,257,798	69.04%
31 Dec, 21	1,927,201	48.34%
30 Sep, 21	1,299,174	-18.52%
30 Jun, 21	1,594,560	433.03%
31 Mar, 21	299,149	-21.44%
31 Dec, 20	380,813	11.36%
30 Sep, 20	341,963	31.39%
30 Jun, 20	260,256	7.22%
31 Mar, 20	242,722	-54.51%
31 Dec, 19	533,628	47.93%
30 Sep, 19	360,726	-

Plus Therapeutics (PSTV) has 2.03M shares outstanding as of 31 Mar 23, down -26.39% compared to the previous quarter.

Institutional Ownership Trend

Date	Ownership %	Change %
31 Mar, 23	0.39%	79.42%
31 Dec, 22	0.70%	94.16%
30 Sep, 22	0.86%	74.99%
30 Jun, 22	1.07%	105.12%
31 Mar, 22	1.01%	89.41%
31 Dec, 21	1.06%	249.25%
30 Sep, 21	0.65%	73.74%
30 Jun, 21	0.94%	1617.37%
31 Mar, 21	0.24%	72.53%
31 Dec, 20	0.58%	215.02%
30 Sep, 20	0.52%	282.60%
30 Jun, 20	0.43%	246.19%
31 Mar, 20	0.42%	49.62%
31 Dec, 19	0.92%	238.71%
30 Sep, 19	0.62%	-

As of 31 Mar 23, Plus Therapeutics is held by 0.39% institutional shareholders, representing a 79.42% growth compared to 31 Dec 22.

Institutional Increased Positions Trend

Date	Increased Positions	Change %
31 Mar, 23	8	-33.33%
31 Dec, 22	12	140.00%
30 Sep, 22	5	-50.00%
30 Jun, 22	10	66.67%
31 Mar, 22	6	-40.00%
31 Dec, 21	10	150.00%
30 Sep, 21	4	-66.67%
30 Jun, 21	12	50.00%
31 Mar, 21	8	33.33%
31 Dec, 20	6	-
30 Sep, 20	6	200.00%
30 Jun, 20	2	-
31 Mar, 20	2	-81.82%
31 Dec, 19	11	10.00%
30 Sep, 19	10	-

8 institutional shareholders have increased their position in PSTV stock as of 31 Mar 23 compared to 12 in the previous quarter (a -33.33% decrease).

Institutional Reduced Positions Trend

Date	Reduced Positions	Change %
31 Mar, 23	6	20.00%
31 Dec, 22	5	-16.67%
30 Sep, 22	6	50.00%
30 Jun, 22	4	33.33%
31 Mar, 22	3	-
31 Dec, 21	-	-100.00%
30 Sep, 21	5	400.00%
30 Jun, 21	1	-
31 Mar, 21	-	-100.00%
31 Dec, 20	3	200.00%
30 Sep, 20	1	-
30 Jun, 20	-	-100.00%
31 Mar, 20	2	-
31 Dec, 19	-	-
30 Sep, 19	-	-

6 institutional shareholders have reduced their position in PSTV stock as of 31 Mar 23 compared to 5 in the previous quarter (a 20.00% increase).

All Institutional Ownership Trend Data

Date	Holdings	Change %	Shares Outstanding	Change %	Ownership %	Change %	Increased Positions	Change %	Reduced Positions	Change %
31 Mar, 23	21	-16.00%	2,026,813	-26.39%	0.39%	79.42%	8	-33.33%	6	20.00%
31 Dec, 22	25	25.00%	2,753,627	-22.37%	0.70%	94.16%	12	140.00%	5	-16.67%
30 Sep, 22	20	5.26%	3,547,118	-0.88%	0.86%	74.99%	5	-50.00%	6	50.00%
30 Jun, 22	19	26.67%	3,578,489	9.84%	1.07%	105.12%	10	66.67%	4	33.33%
31 Mar, 22	15	-6.25%	3,257,798	69.04%	1.01%	89.41%	6	-40.00%	3	-
31 Dec, 21	16	33.33%	1,927,201	48.34%	1.06%	249.25%	10	150.00%	-	-100.00%
30 Sep, 21	12	-14.29%	1,299,174	-18.52%	0.65%	73.74%	4	-66.67%	5	400.00%
30 Jun, 21	14	55.56%	1,594,560	433.03%	0.94%	1617.37%	12	50.00%	1	-
31 Mar, 21	9	-18.18%	299,149	-21.44%	0.24%	72.53%	8	33.33%	-	-100.00%
31 Dec, 20	11	-8.33%	380,813	11.36%	0.58%	215.02%	6	-	3	200.00%
30 Sep, 20	12	100.00%	341,963	31.39%	0.52%	282.60%	6	200.00%	1	-
30 Jun, 20	6	-	260,256	7.22%	0.43%	246.19%	2	-	-	-100.00%
31 Mar, 20	6	-45.45%	242,722	-54.51%	0.42%	49.62%	2	-81.82%	2	-
31 Dec, 19	11	10.00%	533,628	47.93%	0.92%	238.71%	11	10.00%	-	-
30 Sep, 19	10	-	360,726	-	0.62%	-	10	-	-	-

Plus Therapeutics Insider Shareholders Trades

Open Market Insider Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
May 10, 2024	Sims Andrew John Hugh MacIntyre	officer	Chief Financial Officer	P-Purchase	Buy	4,902	$2.04	$10.00K	5,717
May 10, 2024	HEDRICK MARC H	director, officer	Chief Executive Officer	P-Purchase	Buy	12,255	$2.04	$25.00K	12,425
May 10, 2024	Petersen Greg	director	-	P-Purchase	Buy	12,255	$2.04	$25.00K	36,421
May 10, 2024	Clowes Howard	director	-	P-Purchase	Buy	9,804	$2.04	$20.00K	21,497
May 10, 2024	Hawkins Richard J	director	-	P-Purchase	Buy	4,902	$2.04	$10.00K	4,903
May 10, 2024	Lenk Robert P	director	-	P-Purchase	Buy	4,167	$2.04	$8.50K	29,327

Open Market Insider Buys

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
May 10, 2024	Sims Andrew John Hugh MacIntyre	officer	Chief Financial Officer	P-Purchase	Buy	4,902	$2.04	$10.00K	5,717
May 10, 2024	HEDRICK MARC H	director, officer	Chief Executive Officer	P-Purchase	Buy	12,255	$2.04	$25.00K	12,425
May 10, 2024	Petersen Greg	director	-	P-Purchase	Buy	12,255	$2.04	$25.00K	36,421
May 10, 2024	Clowes Howard	director	-	P-Purchase	Buy	9,804	$2.04	$20.00K	21,497
May 10, 2024	Hawkins Richard J	director	-	P-Purchase	Buy	4,902	$2.04	$10.00K	4,903
May 10, 2024	Lenk Robert P	director	-	P-Purchase	Buy	4,167	$2.04	$8.50K	29,327

Insider Sells

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source

All Insider Owners Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
May 10, 2024	Sims Andrew John Hugh MacIntyre	officer	Chief Financial Officer	A-Award	Buy	9,804	$1.79	$17.55K	9,804
May 10, 2024	Sims Andrew John Hugh MacIntyre	officer	Chief Financial Officer	P-Purchase	Buy	4,902	$2.04	$10.00K	5,717
May 10, 2024	HEDRICK MARC H	director, officer	Chief Executive Officer	A-Award	Buy	24,510	$1.79	$43.87K	24,510
May 10, 2024	HEDRICK MARC H	director, officer	Chief Executive Officer	P-Purchase	Buy	12,255	$2.04	$25.00K	12,425
May 10, 2024	Petersen Greg	director	-	P-Purchase	Buy	12,255	$2.04	$25.00K	36,421
May 10, 2024	Petersen Greg	director	-	A-Award	Buy	24,510	$1.79	$43.87K	24,510
May 10, 2024	Clowes Howard	director	-	P-Purchase	Buy	9,804	$2.04	$20.00K	21,497
May 10, 2024	Clowes Howard	director	-	A-Award	Buy	19,608	$1.79	$35.10K	19,608
May 10, 2024	Hawkins Richard J	director	-	A-Award	Buy	9,804	$1.79	$17.55K	9,804
May 10, 2024	Hawkins Richard J	director	-	P-Purchase	Buy	4,902	$2.04	$10.00K	4,903
May 10, 2024	Lenk Robert P	director	-	P-Purchase	Buy	4,167	$2.04	$8.50K	29,327
May 10, 2024	Lenk Robert P	director	-	A-Award	Buy	8,334	$1.79	$14.92K	8,334
Feb 26, 2024	Clowes Howard	director	-	A-Award	Buy	2,250	$2.03	$4.57K	2,250
Feb 26, 2024	LaFrance Norman D.	officer	Chief Medical Officer	A-Award	Buy	24,073	$2.03	$48.87K	24,073
Feb 26, 2024	HEDRICK MARC H	director, officer	Chief Executive Officer	A-Award	Buy	94,012	$2.03	$190.84K	94,012
Feb 26, 2024	Sims Andrew John Hugh MacIntyre	officer	Chief Financial Officer	A-Award	Buy	18,933	$2.03	$38.43K	18,933
Feb 26, 2024	Lenk Robert P	director	-	A-Award	Buy	2,250	$2.03	$4.57K	2,250
Feb 26, 2024	van Es-Johansson An	director	-	A-Award	Buy	2,250	$2.03	$4.57K	2,250
Feb 26, 2024	Hawkins Richard J	director	-	A-Award	Buy	2,250	$2.03	$4.57K	2,250
Feb 26, 2024	Petersen Greg	director	-	A-Award	Buy	2,250	$2.03	$4.57K	2,250

The last insider buy of PSTV was made by Sims Andrew John Hugh MacIntyre on May 10 2024, buying 4,902 shares at $2.04 per share (worth $10.00K).

Plus Therapeutics Insider Ownership Trends

All Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q2 2024	12	-	-
Q1 2024	8	-	-
Q4 2023	8	1	800.00%
Q3 2023	2	-	-
Q2 2023	2	-	-
Q1 2023	8	-	-
Q4 2022	-	1	-
Q2 2022	7	-	-
Q1 2022	1	-	-
Q4 2021	6	-	-
Q3 2021	3	-	-
Q2 2021	9	-	-
Q1 2021	4	-	-
Q4 2020	2	-	-
Q3 2020	4	-	-
Q2 2020	6	-	-
Q1 2020	3	-	-
Q3 2018	6	3	200.00%
Q1 2018	-	16	-
Q4 2017	14	8	175.00%

12 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Plus Therapeutics's insiders, as of Q2 2024.

Open Market Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q2 2024	6	-	-
Q1 2024	-	-	-
Q4 2023	8	1	800.00%
Q3 2023	2	-	-
Q2 2023	2	-	-
Q1 2023	1	-	-
Q4 2022	-	1	-
Q2 2022	7	-	-
Q1 2022	1	-	-
Q4 2021	4	-	-
Q3 2021	3	-	-
Q2 2021	1	-	-
Q1 2021	2	-	-
Q4 2020	2	-	-
Q3 2020	4	-	-
Q2 2020	1	-	-
Q1 2020	-	-	-
Q3 2018	-	-	-
Q1 2018	-	15	-
Q4 2017	-	-	-

As of Q2 2024, Insider owners conducted 6 open market buy trades and 0 open market sell trades of Plus Therapeutics's stocks.

Plus Therapeutics Peer Ownership

Ticker	Company
HOTH	Hoth Therapeutics, Inc.
CFRX	ContraFect Corporation
MNPR	Monopar Therapeutics Inc.
ADTX	Aditxt, Inc.
REVB	Revelation Biosciences, Inc.
QNRX	Quoin Pharmaceuticals, Ltd.
SRZN	Surrozen, Inc.
FWBI	Entero Therapeutics, Inc.
DRMA	Dermata Therapeutics, Inc.
VCNX	Vaccinex, Inc.
VRAX	Virax Biolabs Group Limited
IMMX	Immix Biopharma, Inc.
CYTO	Altamira Therapeutics Ltd.
NRBO	NeuroBo Pharmaceuticals, Inc.
TARA	Protara Therapeutics, Inc.
ATXI	Avenue Therapeutics, Inc.
ZURA	Zura Bio Limited
ENVB	Enveric Biosciences, Inc.
PALI	Palisade Bio, Inc.

PSTV Ownership FAQ

Who Owns Plus Therapeutics?

Plus Therapeutics is owned by institutional shareholders (0.39%), insiders (1.87%), and public (97.74%). The largest institutional shareholder of Plus Therapeutics is WELLS FARGO & COMPANY/MN (0% of total shares) and the top mutual fund owner is PROFESSIONALLY MANAGED PORTFOLIOS (0.00% of total shares).

Who are the major institutional shareholders of Plus Therapeutics?

Plus Therapeutics's major institutional shareholders are WELLS FARGO & COMPANY/MN, NORTHERN TRUST CORP, STATE STREET CORP, VANGUARD GROUP INC, and FMR LLC. The top five shareholders own together 0% of the company's share outstanding.

How many Plus Therapeutics shareholders are there?

As of Mar 2023, there are 21 institutional shareholders of Plus Therapeutics.

What percentage of Plus Therapeutics is owned by WELLS FARGO & COMPANY/MN?

WELLS FARGO & COMPANY/MN owns 0 shares of Plus Therapeutics, representing 0% of the company's total shares outstanding, valued at $0 (as of Jun 2023).

What percentage of Plus Therapeutics is owned by NORTHERN TRUST CORP?

As of Jun 2023, NORTHERN TRUST CORP holds 0 shares of Plus Therapeutics (PSTV), compromising 0% of the company, valued at $0.

What percentage of Plus Therapeutics is owned by STATE STREET CORP?

STATE STREET CORP is the third largest holder of Plus Therapeutics. The company owns 0 of the company's shares outstanding (worth $0).